celecoxib has been researched along with Cancer of Duodenum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
van Heumen, BW | 1 |
Roelofs, HM | 1 |
te Morsche, RH | 1 |
Nagengast, FM | 1 |
Peters, WH | 1 |
Phillips, RK | 1 |
Wallace, MH | 1 |
Lynch, PM | 1 |
Hawk, E | 1 |
Gordon, GB | 1 |
Saunders, BP | 1 |
Wakabayashi, N | 1 |
Shen, Y | 1 |
Zimmerman, S | 1 |
Godio, L | 1 |
Rodrigues-Bigas, M | 1 |
Su, LK | 1 |
Sherman, J | 1 |
Kelloff, G | 1 |
Levin, B | 1 |
Steinbach, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prevention of Progression of Duodenal Adenomas to Cancer in Patients With Familial Adenomatous Polyposis (FAP)[NCT00808743] | Phase 2/Phase 3 | 37 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer[NCT02343614] | Phase 2 | 58 participants (Actual) | Interventional | 2003-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for celecoxib and Cancer of Duodenum
Article | Year |
---|---|
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
Topics: Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; C | 2002 |
1 other study available for celecoxib and Cancer of Duodenum
Article | Year |
---|---|
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
Topics: Adenomatous Polyposis Coli; Adult; Aged; Cadherins; Caspase 3; Celecoxib; Cyclooxygenase 2; Duodenal | 2013 |